Leaflet ACNATAC 10mg / 0.25mg / g gel
Indicated for: acne
Route of administration: cutaneous
Substance: clindamycin + tretinoin (lincosamide antibiotic + retinoid)
ATC: D10AF51 (Dermatologicals | Anti-acne preparations for topical use | Antiinfectives for treatment of acne)
Risk of severe allergic reaction. Seek urgent medical help if serious symptoms occur.
Clindamycin and tretinoin are used together in the treatment of acne vulgaris. Clindamycin is an antibiotic that targets bacteria associated with acne, while tretinoin is a vitamin A derivative that helps reduce inflammation and prevent the formation of new acne lesions.
This combination is available as a gel or cream and should be applied topically as directed by your doctor. It is important to avoid excessive sun exposure and use sunscreen, as tretinoin can increase skin sensitivity to UV rays.
Side effects may include local irritation, redness, dryness, or peeling of the skin. In rare cases, severe allergic reactions may occur, requiring discontinuation of treatment and medical consultation.
Patients should inform their doctor about any other skin products being used or pre-existing dermatological conditions to ensure the safe use of this combination.
General data about ACNATAC 10mg / 0.25mg / g
- Substance: clindamycin + tretinoin
- Date of latest medicines list: 01-05-2022
- Product code: W68671001
- Concentration: 10mg / 0.25mg / g
- Pharmaceutical form: gel
- Quantity: 1
- Product type: Original
- Prescription status: P-RF - Medicines dispensed with a medical prescription that is retained by the pharmacy and cannot be renewed.